United States · Bill · HR
H.R. 4896 (102nd)
To extend the patent term of certain products.
Introduced
9 April 1992
Last action
—
Status
Referred to the House Committee on Judiciary.
Sponsors
—
Subjects
Discovery layer
Source updated
2 June 2021
Summary
Amends Federal patent law to extend the patent term for certain drugs composed of non-steroidal anti-inflammatory agents if during the regulatory review process the patentee: (1) filed a new drug application in 1982; (2) awaited approval by the Food and Drug Administration for at least 78 months; and (3) such new drug application was approved in 1991. Prescribes a formula for patent term extension and sets forth administrative notification procedures.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
2 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN
Introduced in House
summary · EN · 9 April 1992
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/102nd-congress/house-bill/4896
- Open data entity: https://api.congress.gov/v3/bill/102/hr/4896